131I-IPA
131I-TLX-101-002 (IPAX-2)
Phase 1 small_molecule active
Quick answer
131I-IPA for Neoplastic Disease is a Phase 1 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- Neoplastic Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active